I like it, but not too much: Phase 2 ... - Advanced Prostate...

Advanced Prostate Cancer

22,349 members28,110 posts

I like it, but not too much: Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with nmHSPC

Maxone73 profile image
1 Reply

"No patients met the primary endpoint of complete PSA response; however, 4/19 (21%) patients had a PSA decline >50%. Median PSA doubling times were 5.9 months pretreatment, 25.6 months on-treatment (p=0.001), and 9.0 months in the subsequent year off-treatment. The overall median radiographic progression-free survival was not reached. "

jitc.bmj.com/content/11/12/...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
1 Reply
j-o-h-n profile image
j-o-h-n

Shoot..... I keep hearing my echo in here........ Yodeling would be perfect right now.......If I only knew how.......

Note: I wish to offer my apologies if I offended anyone regarding my so-called humor about "race" or "misogyny". To me, humor is boundless and since we entered this word crying, I thought it would be a good idea to exit laughing.

Good Luck, Good Health and Good Humor.

j-o-h-n Sunday 12/17/2023 7:31 PM EST

Not what you're looking for?

You may also like...

Tolerability and treatment response to darolutamide in patients with nmCRPC in the phase III ARAMIS trial

Darolutamide was well tolerated by most patients. Effectiveness related to the PSA decline from...
tango65 profile image

A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen

only 10% of the patients taking curcumin while off ADT for 6 months had PSA progression compared...
George71 profile image

New Protocol of Intermittent ADT for Patients With Metastatic PCa

New Chinese study below [1]. "In the 65 metastatic prostate cancer patients in group 1, androgen...
pjoshea13 profile image

"Early initiation of Lu-177 PSMA radioligand therapy prolongs overall survival in metastatic prostate cancer"

Lu 177 PSMA was effective in prolonging life when used earlier in the disease process....
tango65 profile image

Diethylstilbestrol when faced with "economic constraint".

New study below [1]. We see so many posts on Zytiga, Xtandi & even more expensive drugs. This...
pjoshea13 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.